Klarna, which is known for its popular “buy now, pay later” business, has filed IPO documents with the U.S. Securities and ...

Should you invest in Bicara Therapeutics Inc? Click for more on BCAX's promising cancer treatment, but proceed with caution ...

For this second chapter in our Microsoft @ 50 series, GeekWire spent the past month revisiting Microsoft’s early years, from ...

Sumer Juneja, Managing Partner and Head of EMEA & India Investing at SoftBank, believes that rising wealth and busier ...

“The impact of President Trump’s re-election on the European IPO pipeline won’t be apparent for some time,” said Adam Farlow, ...

With features that simplify goal-setting, asset selection, and regular rebalancing, these apps put powerful portfolio management right at your fingertips.

The SPAC market is chugging along with several IPOs and multiple deals being announced and closed. Although it's great to see this kind of ...

Ahead of FII8’s conference in Riyadh, Sir Martyn Lewis interviewed Nayef Al-Athel, Group Chief Sales and Marketing Officer, ...

For instance, Google shares were trading at 65 times earnings shortly after the IPO. By traditional measures ... Whereas, a ...

Pearl Diver Credit Company is a new CLO Equity CEF with a $136m market cap, 13.2% NAV distribution rate, and plans for ...

Cerebras is pre-IPO, but it has submitted SEC Form S-1 indicating ... The Mayo Clinic, for example, has turned to Cerebras for assistance in developing AI models for healthcare.

IPO: sorrow or success ... option deals that bring both incremental funding and 'big pharma' validation. For example, the Novartis Option Fund (Cambridge, MA, USA) has now invested in at least ...